Deutsche Bank
INBX

Deutsche Bank’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Deutsche Bank’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-54,804
Closed -$1.92M – 3775
2024
Q1 		$1.92M Buy
54,804
+38,496
+236% +$1.4M ﹤0.01% 1685
2023
Q4 		$620K Buy
16,308
+84
+0.5% +$1.8K ﹤0.01% 2269
2023
Q3 		$298K Buy
16,224
+2,156
+15% +$45.1K ﹤0.01% 2518
2023
Q2 		$365K Sell
14,068
-9,775
-41% -$228K ﹤0.01% 2533
2023
Q1 		$450K Buy
23,843
+5,966
+33% +$139K ﹤0.01% 2556
2022
Q4 		$440K Buy
17,877
+3,990
+29% +$117K ﹤0.01% 2516
2022
Q3 		$250K Sell
13,887
-651
-4% -$11.7K ﹤0.01% 2813
2022
Q2 		$165K Sell
14,538
-55,283
-79% -$813K ﹤0.01% 3276
2022
Q1 		$1.56M Sell
69,821
-3,528
-5% -$90.1K ﹤0.01% 2046
2021
Q4 		$3.2M Buy
73,349
+2,769
+4% +$111K ﹤0.01% 1699
2021
Q3 		$2.35M Sell
70,580
-520
-0.7% -$15.8K ﹤0.01% 1982
2021
Q2 		$1.96M Buy
71,100
+65,660
+1,207% +$1.37M ﹤0.01% 2243
2021
Q1 		$109K Sell
5,440
-261
-5% -$7.62K ﹤0.01% 3934
2020
Q4 		$188K Buy
+5,701
New +$152K ﹤0.01% 3500

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Deutsche Bank's INBX Position: Q2 2024 in Review

Deutsche Bank sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 54,804 shares — an estimated $1.92M sold.

Deutsche Bank first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $3.2M in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Deutsche Bank reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 54,804 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.92M.
  • Deutsche Bank first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Deutsche Bank's Inhibrx, Inc. Common Stock position peaked at $3.2M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.